“Compare suppliers above. Sort by price, purity, or supplier rating. Add lines from any vendor to one cart.”— PEPVERA · marketplace


AOD-9604
HGH fragment. Lipolysis without the GH side.
- Sizes available
- 2mg · 5mg
- Tested by
- self-test (ISO 17025 lab)
- Purity
- 99.9% (HPLC)
- Batch ID
- VER-AOD-2
- Made
- April 2026
- Expires
- April 2027
- Suppliers selling this
- 10
The molecule, plainly.
Mechanism, target dose, ramp, and risks — sourced from the supplier's documented protocol.
- Mechanism
- Modified fragment of HGH (176-191). Promotes fat oxidation without affecting IGF-1.
- Target dose
- 300 mcg / day, subq.
- Ramp
- Begin full dose. 8-week cycle.
- Risks
- Mild injection-site reaction.
Draw 20 units.
0.2 mg = 0.20 mL at 1.00 mg/mL. 10.0 doses per vial.
Week 1–2
0.25 mg / wk
Baseline ramp
Week 3–4
0.5 mg / wk
Hold, observe
Week 5–8
1.0–2.0 mg / wk
Ascend
Week 9–12
300 mcg / day, subq.
Terminus
Sourced from public discussion. Anonymized. Original wording preserved. Customers may submit a Field Report after delivery; curated entries appear above with the verified ordinal.
Verified by Janoshik
ISO 17025
Independent third-party HPLC and mass spectrometry on every batch.
Refund on unopened
thirty days
Full refund within thirty days on any unopened vial. No questions.
Replacement on damage
cold-chain
Insulated express. If a vial arrives warm or broken, full replacement.
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Modified fragment of HGH (176-191). Promotes fat oxidation without affecting IGF-1.
Research-grade peptide. Sold for laboratory use only — not for human consumption.
cut · IX · Verified Peptides
AOD-9604 · 2mg